NYSE:CHE - Chemed Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $580.00
  • Forecasted Upside: 20.83 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$480.01
▲ +0.49 (0.10%)

This chart shows the closing price for CHE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Chemed Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHE

Analyst Price Target is $580.00
▲ +20.83% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Chemed in the last 3 months. The average price target is $580.00, with a high forecast of $580.00 and a low forecast of $580.00. The average price target represents a 20.83% upside from the last price of $480.01.

This chart shows the closing price for CHE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Chemed. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/29/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/27/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/25/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/25/2021OppenheimerLower Price TargetOutperform$600.00 ➝ $580.00High
3/10/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$448.00 ➝ $535.00Low
2/19/2020OppenheimerBoost Price TargetOutperform$525.00 ➝ $535.00High
11/25/2019OppenheimerBoost Price TargetMarket Perform$440.00 ➝ $470.00Low
11/1/2019JMP SecuritiesUpgradeMarket Perform ➝ Outperform$490.00High
9/6/2019Bank of AmericaBoost Price TargetBuy$470.00 ➝ $500.00Low
8/1/2019OppenheimerBoost Price TargetOutperform$400.00 ➝ $430.00Low
7/29/2019Royal Bank of CanadaBoost Price TargetSector Perform$405.00Low
4/30/2019OppenheimerBoost Price TargetOutperform$340.00 ➝ $370.00Medium
2/25/2019Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$313.00 ➝ $318.00Low
10/12/2018Bank of AmericaInitiated CoverageBuy$390.00Low
7/30/2018Royal Bank of CanadaBoost Price TargetMarket Perform$321.00Medium
2/16/2018OppenheimerBoost Price TargetOutperform$270.00 ➝ $275.00Low
2/16/2018Royal Bank of CanadaReiterated RatingHold$258.00Low
10/31/2017Royal Bank of CanadaBoost Price TargetPositive ➝ Sector Perform$232.00N/A
10/27/2017OppenheimerBoost Price TargetOutperform$220.00 ➝ $225.00N/A
10/27/2017KeyCorpReiterated RatingHoldN/A
10/3/2017Royal Bank of CanadaReiterated RatingHold$209.00Low
9/1/2017Royal Bank of CanadaReiterated RatingHold$209.00N/A
8/28/2017KeyCorpInitiated CoverageSector Weight ➝ Sector WeightLow
8/13/2017National Bank FinancialUpgradeSector Perform Market Weight ➝ Outperform Market WeightN/A
7/31/2017Royal Bank of CanadaReiterated RatingHold$209.00Low
7/27/2017OppenheimerBoost Price TargetOutperform$200.00 ➝ $220.00Medium
7/5/2017Royal Bank of CanadaReiterated RatingHold$208.00High
11/1/2016Royal Bank of CanadaReiterated RatingSector Perform$162.00 ➝ $148.00N/A
11/1/2016Royal Bank of CanadaLower Price TargetSector Perform$162.00 ➝ $148.00N/A
9/27/2016OppenheimerReiterated RatingOutperform$155.00N/A
9/5/2016National Bank FinancialReiterated RatingSector Perform Market WeightN/A
9/4/2016JMP SecuritiesReiterated RatingHoldN/A
7/27/2016Royal Bank of CanadaReiterated RatingSector Perform$136.00 ➝ $162.00N/A
7/27/2016Royal Bank of CanadaBoost Price TargetSector Perform$136.00 ➝ $162.00N/A
(Data available from 6/23/2016 forward)
Chemed logo
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Read More

Today's Range

Now: $480.01
Low: $478.28
High: $482.97

50 Day Range

MA: $482.57
Low: $459.25
High: $502.91

52 Week Range

Now: $480.01
Low: $417.41
High: $560.00

Volume

60,602 shs

Average Volume

90,831 shs

Market Capitalization

$7.66 billion

P/E Ratio

23.86

Dividend Yield

0.28%

Beta

0.48

Frequently Asked Questions

What sell-side analysts currently cover shares of Chemed?

The following equities research analysts have issued research reports on Chemed in the last twelve months: Oppenheimer Holdings Inc., and Zacks Investment Research.
View the latest analyst ratings for CHE.

What is the current price target for Chemed?

1 Wall Street analysts have set twelve-month price targets for Chemed in the last year. Their average twelve-month price target is $580.00, suggesting a possible upside of 20.8%. Oppenheimer Holdings Inc. has the highest price target set, predicting CHE will reach $580.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $580.00 for Chemed in the next year.
View the latest price targets for CHE.

What is the current consensus analyst rating for Chemed?

Chemed currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CHE will outperform the market and that investors should add to their positions of Chemed.
View the latest ratings for CHE.

What other companies compete with Chemed?

How do I contact Chemed's investor relations team?

Chemed's physical mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company's listed phone number is 513-762-6690. The official website for Chemed is www.chemed.com.